* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Analysis of vagal effects on ventricular rhythm in patients with atrial
Remote ischemic conditioning wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Electrocardiography wikipedia , lookup
Jatene procedure wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Clinical Science (1994) 86, 531-535 (Printed in Great Britain) 53 I Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation Maarten P. VAN DEN BERG, Harry J. G. M. CRIJNS, Jaap HAAKSMA, Jan BROUWER and Kong I. LIE Department of Cardiology, Thoraxcentre, University Hospital Groningen, Groningen, The Netherlands (Received 20 September/6 December 1993; accepted 22 December 1993) 1. Animal studies suggest that the heart-rate-lowering effect of vagal stimulation during atrial fibrillation is due to: (1) a direct depressant effect on atrioventricular node conductivity, (2) enhancement of concealed atrioventricular nodal conduction of atrial impulses through augmenting fibrillatory activity, thereby indirectly prolonging atrioventricular nodal refractoriness. The purpose of the present study was to analyse these effects in man. 2. Sixteen patients with chronic atrial fibrillation were studied. After administration of propranolol (0.2 mg/kg intravenously) baseline ventricular rhythm was recorded (500 R-R intervals). Recordings were repeated after methylatropine (0.02mg/kg intravenously). The shortest R-R interval was taken to represent atrioventricular nodal refractoriness. The ratio of the longest to the shortest R-R interval and the coefficient of variation of R-R intervals were used as parameters of concealed conduction. 3. Methylatropine foremost shortened long R-R intervals: values for the mean, shortest and longest R-R intervals decreased from 834 to 685 ms ( 18%) (P<O.OOI), 573 to 498ms (-13%) (P<O.OOl) and 1228 to 924ms ( - 25%) (P<O.OOl), respectively. Accordingly, the ratio of the longest to the shortest R-R interval decreased 2.12 to 1.89 (-11%) (P<0.05). Also, the coefficient of variation decreased 0.24 to 0.20 ( - 17%) (P< 0.05). 4. This study supports the contention that vagal stimulation lowers ventricular rate during atrial fibrillation both by exerting a direct effect on the atrioventricular node and by augmenting concealed conduction. - INTRODUCTION Clinical experience provides abundant evidence for substantial vagal influences on ventricular rhythm in patients with atrial fibrillation (AF). Vagal manoeuvres, for example carotid sinus massage, lower ventricular rate and may even cause transient asystole. Conversely, after the admini- stration of vagolytic drugs (atropine) marked increases in heart rate generally ensue. The heart-rate-lowering effect of vagal stirnulation during AF is attributed to a direct depressant effect on atrioventricular (AV) nodal conductivity. In addition, it is assumed that vagotonia lowers the heart rate by indirectly increasing AV nodal refractoriness due to an enhancing effect on atrial fibrillatory activity, thereby augmenting concealed AV nodal conduction of atrial impulses [l, 21. However, the evidence to support this assumption is largely circumstantial [3-91. We are aware of only a single animal study that has examined the effect of vagal stimulation during A F on concealed AV nodal conduction [lo]. In the present study we specifically addressed this issue by carefully analysing the effect of methylatropine on ventricular intervals in a group of patients with AF. METH0DS Patients The study group comprised 16 consecutive patients hospitalized for elective electrical cardioversion of chronic AF. Their clinical characteristics are summarized in Table 1. Thirteen patients used digoxin, verapamil or a p-adrenoceptor blocker, or a combination, for control of ventricular rate. Three patients used no such drugs. Patients with suspected or documented sinus node or AV nodal conduction disturbances were excluded, as well as patients with contra-indications for administration of propranolol and atropine. The study was approved by the Ethics Committee of our Institution. Informed consent was obtained from all patients. Experimental protocol Patients were in the post-absorptive and u.nsedated state. Ventricular rhythm was recorded while patients were supine, using a Marquette Holter recorder (series 8500). Three electrocardiographic leads were used: modified leads V1, V5 and Key words: atrial fibrillation, atrioventricular node, atropine, parasympathetic nervous system. Abbreviations: AF, atrial fibrillation; AV, atrioventricular. Correspondence: Dr M. P. van den Berg, Department of Cardiology, Thoraxcentre, University Hospital Groningen, 9700 RB, PO Box 30.001, Groningen, The Netherlands, M. 532 P. van den Table I. Clinical characteristics of the patients. Abbreviations: LA, left atrium; LVEDD, left ventricular enddiastolic diameter; LVESD, left ventricular endsystolic diameter; RA, right atrium Characteristic Value n 16 Mean age (years) 56 (23-81) M/F I0/6 Median duration of arrhythmia (months) 15 (2-144) Underlying heart disease (no. of patients) Rheumatic heart disease Coronary heart disease Hypertensive heart disease ‘Lone’ arrhythmia Miscellaneous Echocardiographic parameters (mm) LVEDD LVESD LA parasternal view LA apical view RA apical view Medication (no. of patients) Digoxin Calcium antagonists PAdrenoceptor blockers 52 *7 35 &6 45 +6 70 +9 61 +8 a 6 3 aVF. A bolus of propranolol (0.2 mg/kg intravenously) was administered to achieve complete /?-adrenoceptor blockade [ll], both to obviate possible confounding effects of sympathetic nervous system activity and to limit potentially hazardous tachycardia. Baseline recordings (e.g. after propranolol) were performed thereafter, lasting 10min. Methylatropine (0.02mg/kg intravenously) was then given and recording was continued for 10min more. The administration of propranolol and methylatropine was unblinded. After the experimental protocol patients underwent electrical cardioversion, as described previously [12]. Berg et al tion two parameters were calculated: the ratio of the longest to the shortest R-R interval and the coefficient of variation of R-R intervals [3-71. To account for the possibility that after full /I-adrenoceptor blockade unopposed vagal activity might cause high-degree AV conduction disturbances, we tested the randomness of the temporal distribution of R-R intervals, as such an AV block would be associated with a non-random ventricular rhythm that might be difficult to detect on a Holter recording. Randomness was assessed using the technique of autocorrelation [13, 141. Correlation coefficients between successive R-R intervals were calculated up to the 50th interval. Autocorrelograms were constructed for graphical display. Statistical analysis As values were normally distributed between patients, data are presented as means+SD. Skewness of R-R interval distributions in individual patients was accounted for by also calculating the mean longest and shortest R-R intervals, and the mean ratio of the two. For comparison of baseline measurements and measurements after methylatropine, paired t-tests were used. Correlation coefficients were calculated using Pearson’s test. We performed the analyses using the Lotus 123 spreadsheet and the statistical package for the social sciences (SPSS). P values <0.05 were considered to be significant. RESULTS Besides transient mild blurring of vision and dryness of mouth in some patients, administration of propranolol and methylatropine was uneventful. Cardioversion of A F to sinus rhythm was achieved in 13 patients. All these patients had a P-R interval ~ 0 . 2 2 In ~ . two of the three other patients normal P-R intervals were noted on prior electrocardiograms during sinus rhythm. All recordings were technically adequate. Data analysis Quantitative data The recordings were processed by an experienced analyst using a Marquette Holter System (Marquette Laser Holter Systems, series SOOOXP). Thereafter, episodes of A F containing 500 ventricular intervals (R-R intervals) were transferred to a P D P 11/73 (DEC) post-processor for further analysis. For each episode of AF, the mean, the shortest (5th percentile) and longest (95th percentile) R-R interval were determined. For graphical display of the effect of methylatropine, interval plots and frequency distribution histograms of the R-R intervals (class width 50 ms) were also generated. The shortest R-R interval was taken to represent AV nodal functional refractoriness [S]. To examine the effect of methylatropine on concealed AV nodal conduc- The effects of methylatropine on R-R intervals and parameters of concealed conduction are shown in Table 2. After methylatropine all intervals were shortened. However, after methylatropine the ratio of the longest to the shortest interval was significantly lower, implying that the effect on long intervals exceeded the effect on short intervals. Methylatropine also lowered the coefficient of variation of R-R intervals. Histograms and interval plots All histograms showed a unimodal distribution of R-R intervals. At baseline a skewed right-hand tail was readily apparent in the majority of histograms. Vagal effects in atrial fibrillation 533 Table 2. Effect of methylatropine on the mean, shortest and longest R-R interval and parameters of concealed conduction. Values are means kSD. Baseline Atropine Change P value (%) Mean R-R interval (ms) Shortest R-R interval (ms) Longest R-R interval (ms) Longest/shortest R-R interval (ms) Coefficients of variation of R-R intervals 834+192 573k118 1228*356 685*164 498k116 924k275 -18 2. I2 kO.28 I .89 k0.23 -I I <0.05 0.24 k0.05' 0.20 k0.05 - I7 <0.05 -13 -25 <0.001 <0.001 <0.001 ~I 250 No. of R-R intervals I00 - I25 75 " l E Y ._ 4 OC 50 c 0 z 25 0 0 1 R-R I25 interval class (ms) 250 No. of R-R intervals Fig. 2. Example of a plot of R-R intervals at baseline ( a ) and after methylatropine ( b ) , corresponding with the histograms in Fig. I. For the sake of clarity only the first 250 intervals are depicted. Besides the loss of long intervals after methylatropine, clearly the 'dispersion' of the intervals is also less. Autocorrelation 0 750 R-R interval class (ms) 1.500 Fig. 1. Example of a histogram of R-R intervals at baseline ( a ) and after methylatropine (b). After methylatropine the histogram is shifted to the left. In addition, the shape of the histogram is altered with diminution of the right-hand tail, indicating that methylatropine foremort affected long intervals. Methylatropine particularly affected this right-hand tail. Fig. 1 shows a representative example of the effect of methylatropine on histogram morphology. In Fig. 2 the corresponding interval plots are shown. Autocorrelation analysis indicated the presence of random R-R interval distributions in all recordings, including those obtained at baseline. With the exception of the first correlation coefficients, which by definition equal + 1, in none of the recordings did subsequent coefficients differ significantly from zero. A representative example of an autocorrelogram is shown in Fig. 3. DISCUSSION To our knowledge, this study is the first attempt systematically to analyse vagal effects on ventricular rhythm in patients with AF. Our findings strengthen the contention that the mechanism underlying the heart-rate-lowering effect is twofold; (1) vagal stimulation exerts a direct depressant effect on AV node conductivity, (2) vagal stimulation also indirectly prolongs AV nodal refractoriness by enhancing concealed conduction. M. P. van den Berg et al. 534 Methodological considerations I 25 50 Coefficient no. Fig. 3. Example of an autocorrelogram. With the exception of the first correlation coefficient none of the coefficients differ significantly from zero, indicating that the distribution of R-R intervals is random. AV node conduction during AF According to the prevailing concept [3-7, lo], during A F the AV node is randomly bombarded by atrial impulses, penetrating it to varying depths, thereby rendering the node refractory for the conduction of subsequent impulses (‘concealed conduction’). Accordingly, an inverse relation exists between atrial and ventricular rate. The shortest R-R interval represents the functional refractory period of the AV node, containing no concealed atrial impulses. The longest R-R interval reflects maximal concealment. In the present study, after methylatropine the shortest R-R interval was significantly decreased, suggesting that vagal stimulation increases AV nodal functional refractoriness during AF. Furthermore, after methylatropine the parameters of concealed AV nodal conduction decreased, suggesting that vagal stimulation also augments concealed conduction. This study therefore supports the presumed dual mechanism underlying vagal effects on ventricular rhythm during A F [1,2]. Our findings in patients fully comply with experimental observations by Moe and Abildskov [lo], who have shown that vagal stimulation during A F in the dog heart both prolongs short and long intervals, the effect on long intervals being more pronounced. An enhancing effect of vagal stimulation on concealed conduction during A F is readily conceivable, considering the effect of vagal stimulation on atrial fibrillatory activity. Vagal activity markedly shortens atrial refractoriness, thereby reducing the wavelength of atrial impulses during AF [S, 91. As a result, fibrillatory activity, e.g. the number of circulating wavelets, increases. This in turn will lead to enhanced concealed AV nodal conduction, as the number of atrial impulses impinging on the node thus increases [3-7, lo]. The majority of patients had associated cardiac disorders. Although the presence of a P-R interval I 0.22 s excludes gross AV conduction disturbances, in patients with rheumatic and coronary heart disease in particular the AV node may have been diseased. In addition, most patients used drugs for the control of ventricular rate, that affect atrial and AV nodal electrophysiological properties. These included digoxin, which exerts both direct and indirect (vagomimetic) effects [lS]. These factors hamper the interpretation of our findings. Ventricular rhythm was random in all recordings, including recordings after full-dose propranolol (baseline). This implies that basal vagal tone (unopposed by sympathetic activity) was not associated with high-degree AV block. Likewise, digoxinintoxication was unlikely, as associated rhythm and conduction disturbances that may otherwise be hard to detect, such as accelerated junctional rhythm and high-degree AV block, would also cause nonrandomness. Finally, the fact that all histograms showed a unimodal distribution (no separate peak of R-R intervals) favours the absence of drug toxicity. At present, ‘in-site’ measurement of concealed AV nodal conduction during A F is not feasible. Instead, we used two indirect parameters of concealed conduction: the ratio of the longest to the shortest R-R interval and the coefficient of variation of R-R intervals. These parameters, however, possibly do not ‘truly’ reflect the degree of concealed conduction. Therefore, no definite conclusions regarding the effect of vagal stimulation on concealed conduction can be drawn from this study. REFERENCES I. Meijler FL. Atrial fibrillation: a new look at an old arrhythmia. J Am Coll Cardiol 1983; 2 391-3. 1. Falk RH. Control of the ventricular rate in atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial fibrillation: mechanisms and management. New York: Raven Press, 1992 255-82. 4. 3. Langendorf R. Pick A, Katz LN. Ventricular response in atrial fibrillation. Role of concealed conduction in the AV junction. Circulation 1965; 32 69-75. Moore EN. Observations on concealed conduction in atrial fibrillation. Circ Res 1967; 21: 2016. 5. Billette J, Nadeau RA, Roberge F. Relation between the minimum RR interval during atrial fibrillation and the functional refractory period of the AV junction. Cardiovasc Res 1974: 8: 347-51. 6. Fujiki A, Tani M, Mizumaki K, Yoshida S, Sasayama. S. Quantification of human concealed atrioventricular nodal conduction: relation to ventricular response during atrial fibrillation. Am Heart J 1990; 120 59E603. 7. Chorro FJ, Kirchhoff CJHJ, Brugada J, Allessie MA. Ventricular response during irregular atrial pacing and atrial fibrillation. Am J Physiol 1990; 259 H I015-21. 8. Allessie MA, Lammers WJEP, Smeets JLRM, Bonke FIM, Hollen J. Total mapping of atrial excitation during acetylcholine-induced atrial flutter and fibrillation in the isolated canine heart. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrial fibrillation. Molndal: AB H i d e 1982 44-59. 9 Allessie MA, Rensma PL, Brugada J, Smeets JLRM. Penn 0, Kirchhoff CJHJ. Pathophysiology of atrial fibrillation. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology: from cell to beside. Philadelphia: WB Saunders, 1990: 54~59. Vagal effects in atrial fibrillation 10. Moe GK, Abildskov ]A. Observation on the ventricular dysrhythmia associated wtih atrial fibrillation in the dog heart. Circ Res 1964; 14: 47-61, II. Jose AD. Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. Am J Cardiol 1966 18: 476-8. 12. van Gelder IC, Crijns HJGM, van Gilst WH, Verver R, Lie KI. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 53.5 1991; 68.41-6. 13. Bootsma BK. Hoelen AJ, Strackee J, Meijler FL. Analysis of RR intervals in patients with atrial fibrillation at rest and during excercise. Circulation 1970 41: 783-94. 14. Rawles JM, Rowland E. Is the pulse in atrial fibrillation irregularly irregular? Br Heart J 1986; 5 6 4-1 I. 15. Watanabe AM. Digitalis and the autonomic nervous system. J Am Coll Cardiol 1985; 5 35-42A.